BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Nventa Biopharmaceuticals Corporation

Nventa Biopharmaceuticals Corporation (TSX:NVN) is developing innovative therapeutics for the treatment of viral infections, with a focus on diseases caused by the human papillomavirus (HPV). Our lead therapeutic candidate is HspE7, a novel therapeutic vaccine designed for the treatment of diseases caused by the human papillomavirus (HPV), one of the most common sexually transmitted diseases in the world. An estimated 80% of sexually active men and women are infected by genital HPV at some point in their lives. Approximately 5.5 million new sexually transmitted HPV infections are reported in the U.S. each year. At least 20 million people in the U.S. are already infected. HPV infection can result in diseases including internal and external genital warts and precancerous conditions, such as cervical and anal dysplasia. Precancerous HPV-related conditions can progress into life-threatening diseases, including cervical, anal, and head and neck cancers.


Contact Details:
6055 Lusk Boulevard
San Diego
California
92121
United States of America
Tel:(858) 202-4900
Fax:(858) 450-6849
Email:dquarry@nventacorp.com
WWW:

www.stressgen.com/




Loading...

Recent Publications by Nventa Biopharmaceuticals Corporation:

Induction of CD4-independent E7-specific CD8+ memory response by heat shock fusion protein.
Infection with human papillomavirus type 16 (HPV16) is strongly associated...
16th October, 2007
Nventa Biopharmaceuticals Corporation, Victoria, BC, Canada V8Z 4B9. Clin Vaccine Immunol. 2007 Aug;14(8):1013-23. Epub 2007 Jun 27.
DOI Direct Link

BioNews Results for Nventa Biopharmaceuticals Corporation:

Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR
Pharma Live:  Oct 9 2008 1:12PM Matching: nventa biopharmaceuticals
Nventa Biopharmaceuticals puts itself on the block
Stockwatch:  Oct 8 2008 10:22PM Matching: nventa biopharmaceuticals

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 252 times since April 2007, the link to the organisation's website has been followed 41 times

Recent Search Terms used to find this page: nventa genital warts | Nventa Victoria BC | nventa download | Nventa Biopharmaceuticals VIctoria BC | Nventa | hpv 6 11 therapeutic warts OR ian fraser OR phase two therapeutic vaccine -cancer | when was nventa biopharmaceuticals established | nventa | nventa biopharmaceuticals bc | Nventa Biopharmaceuticals Corporation victoria | .

Search for more companies in San Diego

Search for more companies in California



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Nventa Biopharmaceuticals Corporation

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.